Semble, a UK-based healthcare company, has secured £30M Series C investment led by Revaia. This investment round also drew in new investor Partech, indicating strong confidence in the company's innovative approach to connected healthcare. The platform, which has been rapidly expanding, has now surpassed 10 million patients, a significant milestone in its development. This funding will enable Semble to further expand its platform and continue to improve patient outcomes.
The connected healthcare platform allows healthcare providers and patients to access medical records and share information seamlessly. This can lead to improved diagnosis, treatment, and patient care. With the increasing adoption of digital health technologies, Semble's platform is well-positioned to meet the growing demand for connected healthcare services.
Revaia's investment in Semble reflects the growing interest in digital health technologies and the potential for innovation in the UK's healthcare sector. The investment will also support Semble's plans to expand its services across Europe. Semble's platform has already made significant inroads in the UK, and this investment will enable the company to accelerate its growth plans.